Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 769 | 756 | 180 | N/A |
| Marketable Securities | 13,336 | N/A | N/A | N/A |
| TOTAL | $15,202 | $774 | $180 | $N/A |
| Non-Current Assets | ||||
| Other Non-Current Assets | 238 | 2,270 | 1 | 0 |
| TOTAL | $238 | $2,270 | $1 | $N/A |
| Total Assets | $15,439 | $3,043 | $180 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | 304 | 47 | N/A |
| Accounts payable and accrued liabilities | 592 | 1,831 | 74 | 0 |
| Accrued Expenses | N/A | 19,943 | 7 | N/A |
| Other current liabilities | N/A | 59 | N/A | N/A |
| TOTAL | $1,977 | $22,517 | $128 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 4,706 | 2,655 | 304 | 0 |
| TOTAL | $4,737 | $2,655 | $304 | $N/A |
| Total Liabilities | $6,714 | $25,172 | $431 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 9,684 | N/A | N/A | N/A |
| Retained earnings | -45,545 | -22,142 | -257 | N/A |
| Other shareholders' equity | -7 | 0 | -5 | 0 |
| TOTAL | $8,725 | $-22,129 | $-251 | $N/A |
| Total Liabilities And Equity | $15,439 | $3,043 | $180 | $0 |